International Vaccine Institute Press Releases - EIN Presswire

Published on September 10, 2021 - 09:08 GMT

IVI’s 20th International Vaccinology Course brings virtual training to vaccine professionals & students in 155 countries

SEOUL, REPUBLIC OF KOREA, September 10, 2021 /⁨EINPresswire.com⁩/ -- The International Vaccine Institute’s (IVI) 20th International Vaccinology Course (IVC) concluded today, bringing together 7,350 registered trainees and 27 faculty members for 5 days of …

Distribution channels: Education, Healthcare & Pharmaceuticals Industry ...

Published on August 18, 2021 - 08:22 GMT

IVI appoints ballerina Sae Eun Park to IVI Goodwill Ambassador

SEOUL, REPUBLIC OF KOREA, August 18, 2021 /⁨EINPresswire.com⁩/ -- The International Vaccine Institute (IVI) appointed Sae Eun Park, an award-winning ballet dancer from Korea, an IVI Goodwill Ambassador during a virtual ceremony in Seoul today. Ms. Park …

Distribution channels: Culture, Society & Lifestyle ...

Published on July 26, 2021 - 09:07 GMT

THECA consortium begins Vi-TT typhoid conjugate vaccine phase IV effectiveness study in Ghana

SEOUL, RE, July 26, 2021 /⁨EINPresswire.com⁩/ -- The International Vaccine Institute (IVI) announced today the start of a cluster-randomized, controlled Phase IV trial to assess the effectiveness of Typbar® typhoid conjugate vaccine (TCV) in preventing …

Distribution channels: Science ...

Published on July 15, 2021 - 09:58 GMT

IVI welcomes Bangladesh as state party with ratification ceremony

SEOUL, REPUBLIC OF KOREA, July 15, 2021 /⁨EINPresswire.com⁩/ -- The International Vaccine Institute (IVI) hosted a ceremony at headquarters today honoring the People’s Republic of Bangladesh’s ratification of the IVI Establishment Agreement. Over 20 years …

Distribution channels: International Organizations ...

Published on July 5, 2021 - 13:36 GMT

IVI and KNUST establish collaborating center to conduct vaccine research and development for global health

SEOUL, REPUBLIC OF KOREA, July 5, 2021 /⁨EINPresswire.com⁩/ -- The International Vaccine Institute (IVI) and the Kwame Nkrumah University of Science and Technology (KNUST) opened the KNUST-IVI Collaborating Center today with a ceremony at KNUST/ Agogo …

Distribution channels: Science ...

Published on June 29, 2021 - 13:24 GMT

IVI organizes ROK-Australia-ASEAN Vaccine Forum to promote inclusive and sustainable recovery from the COVID-19 pandemic

The ROK-Australia-ASEAN Vaccine Forum took place in hybrid live/virtual format with transmission from Seoul on June 29, 2021 SEOUL, REPUBLIC OF KOREA, June 29, 2021 /⁨EINPresswire.com⁩/ -- The International Vaccine Institute (IVI) organized, and the …

Distribution channels: World & Regional

Published on May 31, 2021 - 06:19 GMT

IVI to develop an adaptive Phase 1b/2a schistosomiasis vaccine clinical trial

SEOUL, REPUBLIC OF KOREA, May 31, 2021 /⁨EINPresswire.com⁩/ -- The International Vaccine Institute (IVI) announced today that the Bill & Melinda Gates Foundation awarded a grant to IVI to develop an adaptive trial design protocol for a Phase 1b/2a …

Distribution channels: Science ...

Published on May 19, 2021 - 05:20 GMT

International Vaccine Institute and FII Institute sign MOU to cooperate on scientific research and publication

The agreement is an effort to further scientific research in infectious diseases and make knowledge more accessible through advocacy and joint publications. SEOUL, REPUBLIC OF KOREA, May 19, 2021 /⁨EINPresswire.com⁩/ -- The International Vaccine Institute …

Distribution channels: Science ...

Published on April 27, 2021 - 13:29 GMT

Webinar: COVID-19 and Public Governance, co-hosted by IVI, Konrad-Adenauer-Stiftung, and the Embassy of Korea in Germany

Registration available at ivi.int/covid-19-and-public-governance/ SEOUL, REPUBLIC OF KOREA, April 27, 2021 /⁨EINPresswire.com⁩/ -- The International Vaccine Institute (IVI), Konrad-Adenauer-Stiftung e.V. (KAS), and the Embassy of Korea in Germany will co- …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on April 1, 2021 - 05:39 GMT

IVI and Institut Pasteur Korea Sign MOU for Research and Development of Infectious Disease Therapeutics and Vaccines

GYEONGDO-DO AND SEOUL, REPUBLIC OF KOREA, April 1, 2021 /⁨EINPresswire.com⁩/ -- The International Vaccine Institute (IVI) and the Institut Pasteur Korea (IPK) signed a memorandum of understanding (MOU) for mutual collaboration in the research and …

Distribution channels: Science ...

Published on March 12, 2021 - 07:07 GMT

IVI signs Memorandum of Understanding with the Nepal Health Research Council

SEOUL, REPUBLIC OF KOREA, March 12, 2021 /⁨EINPresswire.com⁩/ -- The International Vaccine Institute (IVI) and the Nepal Health Research Council (NHRC) signed a Memorandum of Understanding (MoU) today during a virtual ceremony, laying the foundation for …

Distribution channels: Science ...

Published on March 9, 2021 - 06:55 GMT

IVI welcomes Bangladesh’s accession to IVI

The IVI Establishment Agreement remains open for accession by any state or intergovernmental organization SEOUL, REPUBLIC OF KOREA, March 9, 2021 /⁨EINPresswire.com⁩/ -- The International Vaccine Institute (IVI) welcomes the Cabinet of Bangladesh’s …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on February 22, 2021 - 06:26 GMT

George Bickerstaff re-elected Chairperson of the International Vaccine Institute’s Board of Trustees

SEOUL, REPUBLIC OF KOREA, February 22, 2021 /⁨EINPresswire.com⁩/ -- The International Vaccine Institute (IVI) announced today that its Board of Trustees (BOT) re-elected Mr. George Bickerstaff as Chairperson of the BOT. His second three-year term will …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on January 26, 2021 - 00:59 GMT

GI-Cell, IVI sign MOU to develop next-generation COVID-19 vaccine

Aims to prioritize supply to Korea & developing countries by developing a vaccine that accommodates mass supply, mutation response, safety, patient convenience SEOUL, REPUBLIC OF KOREA, January 26, 2021 /⁨EINPresswire.com⁩/ -- - To cooperate in …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on December 17, 2020 - 07:39 GMT

IVI-SK’s new typhoid conjugate vaccine meets primary endpoints in phase III study in Nepal

Vi-DT typhoid conjugate vaccine, developed by the International Vaccine Institute and SK bioscience, has met the primary endpoints in a phase III study in Nepal SEOUL, REPUBLIC OF KOREA, December 17, 2020 /⁨EINPresswire.com⁩/ -- Vi-DT typhoid conjugate …

Distribution channels: Healthcare & Pharmaceuticals Industry, International Organizations ...

Published on November 25, 2020 - 15:38 GMT

IVI and the Ministry of Foreign Affairs of Ecuador exchange MOU to pursue global health research & development

SEOUL, REPUBLIC OF KOREA, November 25, 2020 /⁨EINPresswire.com⁩/ -- The International Vaccine Institute (IVI) and the Ministry of Foreign Affairs and Human Mobility of Ecuador exchanged a memorandum of understanding (MOU) yesterday at IVI headquarters in …

Distribution channels: Healthcare & Pharmaceuticals Industry, International Organizations ...

Published on November 18, 2020 - 06:05 GMT

IVI, Vaccine Innovative Technology ALliance Korea (VITAL-Korea) to partner for innovative vaccine R&D

SEOUL, REPUBLIC OF KOREA, November 18, 2020 /⁨EINPresswire.com⁩/ -- The International Vaccine Institute (IVI) and the Vaccine Innovative Technology ALliance Korea (VITAL-Korea) agreed to join forces to promote vaccine research and development for global …

Distribution channels: Healthcare & Pharmaceuticals Industry, International Organizations ...

Published on October 27, 2020 - 08:42 GMT

The International Vaccine Institute Supports a Global Campaign to Reduce the Spread of Covid-19

SEOUL, REPUBLIC OF KOREA, October 27, 2020 /⁨EINPresswire.com⁩/ -- The International Vaccine Institute (IVI) is partnering with the World Sanity Foundation (WSF) in a campaign to encourage the use of face masks in an effort to reduce the spread of COVID-19 …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...